ES2080458T3 - Nuevos compuestos aromaticos de derivados de imina, su procedimiento de preparacion y su utilizacion en medicina humana y veterinaria asi como en cosmetica. - Google Patents

Nuevos compuestos aromaticos de derivados de imina, su procedimiento de preparacion y su utilizacion en medicina humana y veterinaria asi como en cosmetica.

Info

Publication number
ES2080458T3
ES2080458T3 ES92401320T ES92401320T ES2080458T3 ES 2080458 T3 ES2080458 T3 ES 2080458T3 ES 92401320 T ES92401320 T ES 92401320T ES 92401320 T ES92401320 T ES 92401320T ES 2080458 T3 ES2080458 T3 ES 2080458T3
Authority
ES
Spain
Prior art keywords
alkyl
lower alkyl
imina
cosmetics
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92401320T
Other languages
English (en)
Inventor
Jean-Philippe Rocher
Jean-Michel Bernardon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Application granted granted Critical
Publication of ES2080458T3 publication Critical patent/ES2080458T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/58—Derivatives of thiocarboxylic acids, the doubly-bound oxygen atoms being replaced by nitrogen atoms, e.g. imino-thio ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
    • C07C257/08—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

COMPUESTOS BIAROMATICOS QUE RESPONDEN A LA SIGUIENTE FORMULA GENERAL (I): EN LA QUE: R1 ES H, OH, _CH3, _CH2OH, -COR7, -CH(OH)CH3, -CH2OCOR8, ETC, R7 ES H, OH, -OR10, N(R''R"), ALQUILO INFERIOR, ETC, R8 ES ALQUILO LINEAL O RAMIFICADO, O EL RESTO DE UN AZUCAR, R9 ES OH, ALQUILO INFERIOR O N(R''R"), SIENDO R10 ALQUILO O ALQUENILO, R'' Y R" SON H, ALQUILO INFERIOR, ARILO, ARALQUILO, ETC, O R'' Y R" FORMAN UN HETEROCICLO, R2 Y R6 SON H, OH, ALQUILO INFERIOR, ETC, R3 Y R5 SON ALQUILO ALFA-LAFA''-DISUSTITUIDO O CICLOALQUILO, R4 ES H, OH, ALCOXI, ALQUILO ALFA-ALFA''-DISUSTITUIDO, R3 Y R4 O R4 Y R5 TOMADOS JUNTOS PUEDEN FORMAR UN CICLO DE 5 O 6 ESLABONES, Z ES O, S, -CH=CR11 -, SIENDO R11 H, OH O ALQUILO INFERIOR, SIENDO R12 H O ALQUILO INFERIOR, X ES (I) R16, OR16, EL -SR16 O N(R16R17) SIENDO R16 Y R17, H, ALQUILO INFERIOR, FLUOROALQUILO, ETC, SIENDO R14 ALQUILO, SIENDO R15 ALQUILO INFERIOR O FLUOROALQUILO INFERIOR, SALVO LOS COMPUESTOS DE FORMULA (I) CUANDO R3 Y R5 SON IDENTICOS Y X REPRESENTA EL RADICAL DICHOS COMPUESTOS DE FORMULA (I).
ES92401320T 1991-05-15 1992-05-14 Nuevos compuestos aromaticos de derivados de imina, su procedimiento de preparacion y su utilizacion en medicina humana y veterinaria asi como en cosmetica. Expired - Lifetime ES2080458T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105883A FR2676440B1 (fr) 1991-05-15 1991-05-15 Nouveaux composes aromatiques derives d'imine, leur procede de preparation et leur utilisation en medecine humaine et veterinaire ainsi qu'en cosmetique.

Publications (1)

Publication Number Publication Date
ES2080458T3 true ES2080458T3 (es) 1996-02-01

Family

ID=9412804

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92401320T Expired - Lifetime ES2080458T3 (es) 1991-05-15 1992-05-14 Nuevos compuestos aromaticos de derivados de imina, su procedimiento de preparacion y su utilizacion en medicina humana y veterinaria asi como en cosmetica.

Country Status (10)

Country Link
EP (1) EP0514269B1 (es)
JP (1) JP3233451B2 (es)
AT (1) ATE129698T1 (es)
AU (1) AU650972B2 (es)
CA (1) CA2068696A1 (es)
DE (1) DE69205725T2 (es)
DK (1) DK0514269T3 (es)
ES (1) ES2080458T3 (es)
FR (1) FR2676440B1 (es)
GR (1) GR3018702T3 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264578A (en) 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5534641A (en) 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5675033A (en) 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6942980B1 (en) 1995-09-01 2005-09-13 Allergan, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5741896A (en) 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
US6369261B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6380256B1 (en) 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6369225B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6387951B1 (en) 2000-08-29 2002-05-14 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669974A (en) * 1971-03-25 1972-06-13 Usv Pharma Corp N,n1-disubstituted benzamidines
US4264505A (en) * 1978-06-12 1981-04-28 Usv Pharmaceutical Corporation Substituted benzylidene imines
LU86258A1 (fr) * 1986-01-21 1987-09-03 Rech Dermatologiques C I R D S Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Also Published As

Publication number Publication date
FR2676440A1 (fr) 1992-11-20
DE69205725T2 (de) 1996-05-30
EP0514269B1 (fr) 1995-11-02
CA2068696A1 (fr) 1992-11-16
EP0514269A1 (fr) 1992-11-19
DK0514269T3 (da) 1996-03-04
GR3018702T3 (en) 1996-04-30
AU1627392A (en) 1992-11-19
DE69205725D1 (de) 1995-12-07
ATE129698T1 (de) 1995-11-15
FR2676440B1 (fr) 1993-07-30
JP3233451B2 (ja) 2001-11-26
AU650972B2 (en) 1994-07-07
JPH05221951A (ja) 1993-08-31

Similar Documents

Publication Publication Date Title
ES2080458T3 (es) Nuevos compuestos aromaticos de derivados de imina, su procedimiento de preparacion y su utilizacion en medicina humana y veterinaria asi como en cosmetica.
ATE119889T1 (de) S-triazinderivate mit benzalmalonaten als substituenten, verfahren zu ihrer herstellung, diese enthaltende kosmetische zubereitungen mit filternder wirkung und ihre verwendung als schutzmittel für haut und haar.
NZ240189A (en) Aryl substituted amides, carbamates, carbonates, ketones and esters; preparation and pharmaceutical/cosmetic compositions thereof
DK23189D0 (da) Aromatiske estere og thioestere, deres fremstilling og deres anvendelse til human- eller veterinaermedicinske og kosmetiske formaal
ATE275929T1 (de) Verwendung von aminosubstituierten hydroxybenzophenonen als photostabile uv-filter in kosmetischen und pharmazeutischen zubereitungen
ATE98468T1 (de) 2-aminopyrimidin-3-oxid-derivate enthaltende zusammensetzungen zur verwendung zum vermindern des haarausfalles und zum induzieren und stimulieren des haarwuchses und neue von 2aminopyrimidin-3-oxid abgeleitete verbindungen.
ES2080457T3 (es) Compuestos bioaromaticos derivados de un motivo salicilico, su procedimiento de preparacion y su utilizacion en medicina humana y veterinaria asi como en cosmetica.
DK114088A (da) 5-alkoxy-2,4-diamino-alkylbenzener samt haarfarvningsmiddel med 5-alkoxy-2,4-diamino-alkyl-benzener
SE8700458D0 (sv) Fergkomposition for keratinfibrer och i synnerhet for menniskohar baserad pa halogenerade nitroaniliner, forfarande for fergning med anvendning av fergkompositionen och nya anvenda halogenerade 2-nitroaniliner
GB2244486B (en) Therapeutic N-(2-biphenylyl)guanidine derivatives
ES2058852T3 (es) Procedimiento de tincion de las fibras queratinicas con amino-indoles, composiciones y dispositivos de utilizacion.
ES2156345T3 (es) Nuevos compuestos biarilos heterociclicos y su utilizacion en medicina humana o veterinaria asi como en cosmetica.
JPS6440449A (en) Substituted 2-nitromethaphenylenediamine, manufacture and hair dye composition
ES2069714T3 (es) Esteres biaromaticos, su procedimiento de preparacion y su utilizacion en medicina humana o veterinaria y en cosmetica.
IL97511A0 (en) Urea derivatives,their preparation and medical products containing them
DK11491A (da) Haarfarvemiddel
SE8703068L (sv) Komposition for att inducera och stimulera hartillvext och minska haravfall baserad pa pyrimidinderivat
SE8502910D0 (sv) Aryl-10-dihydroxi-1,8-antroner och deras salter, forfarande for framstellning derav och anvendning derav inom human- eller veterinermedicinen samt inom kosmetiken
TH34361A (th) สารประกอบ

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 514269

Country of ref document: ES